newsfilter
← Latest News
Business Wire·

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Achieved record total revenue of $54.3M including record product revenue of $52.9M Product revenue increased 27% versus prior year and 14% over the prior quarter Ended Q3 with $69.4M in cash, cash equivalents and